Phase 1/2 Study of a Plant-Based Seasonal Recombinant Trivalent VLP Influenza Vaccine

​ Conditions: Influenza

Interventions: Biological: Recombinant Influenza vaccine candidate; Biological: Commercial Influenza vaccine

Sponsors: Aramis Biotechnologies Inc.

Not yet recruiting Conditions: Influenza
Interventions: Biological: Recombinant Influenza vaccine candidate; Biological: Commercial Influenza vaccine
Sponsors: Aramis Biotechnologies Inc.
Not yet recruiting